Molybdenum-99 for Medical Imaging (2016)Nuclear and Radiation Studies Board
Each report is produced by a committee of experts selected by the Academy to address a particular statement of task and is subject to a rigorous, independent peer review; while the reports represent views of the committee, they also are endorsed by the Academy. Learn more on our expert consensus reports.
The report examines the production and utilization of molybdenum-99 and associated medical isotopes used in medical imaging. It also assesses progress made toward eliminating highly enriched uranium (HEU) from the targets used to produce molybdenum-99 production and promoting the utilization of molybdenum-99 from non-HEU sources. The report was mandated by the American Medical Isotopes Production Act of 2012 and it is the second of the two studies that derived from the mandate to the Academies. The first study examined the use of highly enriched uranium in reactor fuel and was published in the report titled Reducing the Use of Highly Enriched Uranium in Civilian Research Reactors.